Skip to main content
Saturday, August 15, 2026
BTC $63,084 ▼ 0.40%
GOKHSHTEIN.
Live WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
More SectionsDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
Subscribe
LIVE
BTC$63,084down−0.40%ETH$1,883up+0.00%SOL$75.48down−0.40%XRP$1.01down−0.50%LINK$9.50up+7.20%ADA$0.180down−1.10%S&P 5007,786down−0.17%Nasdaq26,729down−0.28%Dow53,732down−0.20%RUT3,068up+0.51%TNX4.70%up+1.19%TYX5.27%up+1.00%FVX4.36%up+1.14%IRX3.70%down−0.22%VIX14.25down−2.60%GOLD$4,437.30up+0.38%SILVER$65.11up+0.18%OIL$82.40up+1.42%DXY99.64down−0.03%NVDA$225.16down−0.06%AAPL$305.93up+0.22%TSLA$342.27up+0.68%META$589.85down−0.86%MSFT$495.40down−0.30%AMZN$262.65down−0.94%GOOGL$345.90down−0.13%Fear & Greed34 — FearBTC$63,084down−0.40%ETH$1,883up+0.00%SOL$75.48down−0.40%XRP$1.01down−0.50%LINK$9.50up+7.20%ADA$0.180down−1.10%S&P 5007,786down−0.17%Nasdaq26,729down−0.28%Dow53,732down−0.20%RUT3,068up+0.51%TNX4.70%up+1.19%TYX5.27%up+1.00%FVX4.36%up+1.14%IRX3.70%down−0.22%VIX14.25down−2.60%GOLD$4,437.30up+0.38%SILVER$65.11up+0.18%OIL$82.40up+1.42%DXY99.64down−0.03%NVDA$225.16down−0.06%AAPL$305.93up+0.22%TSLA$342.27up+0.68%META$589.85down−0.86%MSFT$495.40down−0.30%AMZN$262.65down−0.94%GOOGL$345.90down−0.13%Fear & Greed34 — Fear
GOKHSHTEIN.
Media · Est. 2019
The front page of everything. Breaking news and sharp analysis across politics, markets, crypto, technology, and sports — with live market data built in.
Markets
Market OverviewDigital AssetsU.S. EquitiesMacro & RatesResearch
Editorial
Politics & PolicyTechnologySports BusinessResearch
Terminal
GMarketsGo PRO
Company
AboutContactEditorial StandardsCorrectionsAdvertiseSubscribe
Legal
Privacy PolicyTerms of ServiceDisclosures
© 2026 Gokhshtein Media. All rights reserved.
PrivacyTermsDisclosures
Tag

compounding

1 article

Peptide Lobby Wins FDA Panel Vote Over Agency Scientists' Objections
Politics & Policy21d ago
Peptide Lobby Wins FDA Panel Vote Over Agency Scientists' Objections
The Pharmacy Compounding Advisory Committee voted 9-4 to add 20 peptide substances to the permitted compounding list, overriding internal FDA safety warnings.